Revvity to Present at J.P. Morgan Healthcare Conference
19 Diciembre 2023 - 7:00AM
Business Wire
Revvity, Inc. (NYSE: RVTY) will present at the 42nd annual J.P.
Morgan Healthcare Conference on Tuesday, January 9, 2024 at 10:30
a.m. PT in San Francisco, CA.
President and Chief Executive Officer Prahlad Singh will provide
an update on the Company and its strategic priorities.
To access the presentation, a live audio webcast will be
available via this page. A replay of the presentation will be
posted on the Revvity Investor Relations website after the event
and will be available for at least 30 days.
About Revvity
At Revvity, “impossible” is inspiration, and “can’t be done” is
a call to action. Revvity provides health science solutions,
technologies, expertise and services that deliver complete
workflows from discovery to development, and diagnosis to cure.
Revvity is revolutionizing what’s possible in healthcare, with
specialized focus areas in translational multi-omics technologies,
biomarker identification, imaging, prediction, screening, detection
and diagnosis, informatics and more.
With 2022 revenue of more than $3 billion and over 11,000
employees, Revvity serves customers across pharmaceutical and
biotech, diagnostic labs, academia and governments. It is part of
the S&P 500 index and has customers in more than 190
countries.
Stay updated by following our Newsroom, LinkedIn, X, YouTube,
Facebook and Instagram.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231219924888/en/
Investor Relations: Steve Willoughby
steve.willoughby@revvity.com
Media Relations: Chet Murray (781) 663-5719
chet.murray@revvity.com
Revvity (NYSE:RVTY)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Revvity (NYSE:RVTY)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024